Literature DB >> 1400567

Partial responses to antineoplastic drug therapy: what do they mean?

M Markman.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1400567     DOI： 10.1007/bf01209482

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


× No keyword cloud information.
  15 in total

1.  Preliminary report of the National Cancer Data Base.

Authors:  H R Menck; L Garfinkel; G D Dodd
Journal:  CA Cancer J Clin       Date:  1991 Jan-Feb       Impact factor: 508.702

2.  An argument in support of cost-effectiveness analysis in oncology.

Authors:  M Markman
Journal:  J Clin Oncol       Date:  1988-06       Impact factor: 44.544

3.  Design of phase I and II clinical trials in cancer: a statistician's view.

Authors:  N L Geller
Journal:  Cancer Invest       Date:  1984       Impact factor: 2.176

4.  Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation.

Authors:  B E Johnson; J Grayson; R W Makuch; R I Linnoila; M J Anderson; M H Cohen; E Glatstein; J D Minna; D C Ihde
Journal:  J Clin Oncol       Date:  1990-03       Impact factor: 44.544

5.  Reporting results from chemotherapy trials. Does response make a difference in patient survival?

Authors:  R K Oye; M F Shapiro
Journal:  JAMA       Date:  1984-11-16       Impact factor: 56.272

6.  Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation.

Authors:  H Schipper; J Clinch; A McMurray; M Levitt
Journal:  J Clin Oncol       Date:  1984-05       Impact factor: 44.544

Review 7.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1992-01-04       Impact factor: 79.321

8.  Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

Authors:  C G Moertel; T R Fleming; J S Macdonald; D G Haller; J A Laurie; P J Goodman; J S Ungerleider; W A Emerson; D C Tormey; J H Glick
Journal:  N Engl J Med       Date:  1990-02-08       Impact factor: 91.245

9.  Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.

Authors:  E Rapp; J L Pater; A Willan; Y Cormier; N Murray; W K Evans; D I Hodson; D A Clark; R Feld; A M Arnold
Journal:  J Clin Oncol       Date:  1988-04       Impact factor: 44.544

10.  Effective surgical adjuvant therapy for high-risk rectal carcinoma.

Authors:  J E Krook; C G Moertel; L L Gunderson; H S Wieand; R T Collins; R W Beart; T P Kubista; M A Poon; W C Meyers; J A Mailliard
Journal:  N Engl J Med       Date:  1991-03-14       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.